A new trading day began on Monday, with ProKidney Corp (NASDAQ: PROK) stock price down -11.46% from the previous day of trading, before settling in for the closing price of $0.67. PROK’s price has ranged from $0.46 to $2.59 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 9.74%. With a float of $94.19 million, this company’s outstanding shares have now reached $129.54 million.
In an organization with 204 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -60453.59%, and the pretax margin is -54267.65%.
ProKidney Corp (PROK) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ProKidney Corp is 27.29%, while institutional ownership is 41.69%. The most recent insider transaction that took place on Apr 22 ’25, was worth 276,366. In this transaction Add’l Rep. Persons-see Ex.99-1 of this company bought 387,393 shares at a rate of $0.71, taking the stock ownership to the 73,842,723 shares. Before that another transaction happened on Apr 17 ’25, when Company’s Add’l Rep. Persons-see Ex.99-1 bought 25,000 for $0.75, making the entire transaction worth $18,690. This insider now owns 73,455,330 shares in total.
ProKidney Corp (PROK) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 9.74% per share during the next fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
Here are ProKidney Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 559.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.60, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
Let’s dig in a bit further. During the last 5-days, its volume was 3.94 million. That was better than the volume of 0.83 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.08%.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 10.22%, which indicates a significant increase from 10.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 164.75% in the past 14 days, which was higher than the 125.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8004, while its 200-day Moving Average is $1.3919. However, in the short run, ProKidney Corp’s stock first resistance to watch stands at $0.6790. Second resistance stands at $0.7659. The third major resistance level sits at $0.8354. If the price goes on to break the first support level at $0.5226, it is likely to go to the next support level at $0.4531. Assuming the price breaks the second support level, the third support level stands at $0.3662.
ProKidney Corp (NASDAQ: PROK) Key Stats
With a market capitalization of 173.31 million, the company has a total of 292,698K Shares Outstanding. Currently, annual sales are 80 K while annual income is -61,190 K. The company’s previous quarter sales were 230 K while its latest quarter income was -16,730 K.
